Shares of Amdocs Limited (NASDAQ:DOX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $101.83.
Several research analysts have recently commented on the stock. Stifel Nicolaus initiated coverage on shares of Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target for the company. Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 14th. Finally, Barclays lowered their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th.
Get Our Latest Analysis on DOX
Hedge Funds Weigh In On Amdocs
Amdocs Price Performance
Shares of NASDAQ DOX opened at $87.18 on Thursday. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $10.25 billion, a price-to-earnings ratio of 20.56, a price-to-earnings-growth ratio of 1.46 and a beta of 0.74. Amdocs has a twelve month low of $74.41 and a twelve month high of $94.04. The business has a 50 day simple moving average of $88.08 and a 200-day simple moving average of $84.03.
Amdocs Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.479 dividend. This represents a $1.92 annualized dividend and a yield of 2.20%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs’s payout ratio is currently 45.28%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Warren Buffett Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Excel Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.